JENNIFER DRESSMAN INTERVIEW

TiPS magazine has just published an interesting interview with Jennifer Dressman, Professor of Pharmaceutical Technology at the Goethe University in Frankfurt am Main, Germany. […]

Read more

New biorelevant.com website is live!

We have just re-launched biorelevant.com. It’s very easy to use to help you place orders quickly and get the best results from our products. […]

Read more

How GSK Used Biorelevant Media

How GlaxoSmithKline (GSK) used Biorelevant Media (FaSSIF, FeSSIF and FaSSGF) to improve the solubility and dissolution of their novel drug danirixin for improved bioavailability. […]

Read more

Drug Substance vs. Drug Product

The difference between ‘drug substance’ and ‘drug product’ is important to understand and can really help with the successful development of your pharmaceutical drug. […]

Read more

The Importance Of Fasted + Fed States

Explaining the difference between ‘fasted’ (without food) and ‘fed’ (with food) states and how they impact on the solubility and dissolution of a drug.  […]

Read more

Novel Dissolution Testing By BMS

In this post you can learn more about novel biorelevant dissolution testing methods performed by Bristol-Myers Squibb and used to assess pH-dependency of NCEs.  […]

Read more

Unilever’s Use Of Biorelevant Media

Biorelevant Media can assist with the development of your oral dosage form and Unilever’s study on capsule shell material can help show you how¹. […]

Read more

What Are The Differences Between FaSSIF-V2 And FaSSIF?

FaSSIF-V2 and FaSSIF are types of fasted state Biorelevant Media simulating small intestinal fluid. ’Fasted state’ simply means without food or before a meal (pre-prandial). […]

Read more

FeSSIF-V2

What Are The Differences Between FeSSIF-V2 And FeSSIF?

FeSSIF and FeSSIF-V2 are different types of Biorelevant Media. They simulate what human intestinal fluids are like after a meal is eaten (Fed State). […]

Read more